Casting
State-of-the-art investment casting technology, for precision, reliability and cost-efficiency
Marle has developed air and vacuum investment casting capabilities that benefit orthopaedic implant production in many ways.
- Large freedom of design, well suited to shoulder and knee implants
- Vast choice of medical- specific alloys and superalloys
- Tight dimensional tolerances
- High reproducibility and consistency
- Specific heat treatment to enhance physical and chemical properties
Marle maintains a complete, high production investment casting facility of 5800 m². Over 170 tons of cobalt and nickel base alloys are used to cast the 35 000 monthly orthopaedic parts.
With two casting lines each comprised of an induction furnace and a cluster firing furnace, Marle’s production facilities offer reactivity and flexibility regardless of volume.
Marle Group to exhibit for the first time in China, for the 14th Annual Congress of Chinese Orthopaedic Association, in Shanghai, from 15th to 17th November 2019.
DENTRESSANGLE, the family-investment holding company, has entered into exclusive negotiations to acquire a majority stake in MARLE.
Marle to exhibit for the seventh time at OMTEC, Chicago.